Assessing the impact of Chronic Pulmonary Aspergillosis on health and well-being

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to develop and validate a new questionnaire specifically designed to measure health-related quality of life (HRQoL) in patients suffering from Chronic Pulmonary Aspergillosis (CPA). By focusing on the unique challenges faced by these patients, the CPA-HAQ questionnaire will be utilized in clinical research and trials to better understand the disease's impact on daily living. The study will involve patients who meet specific eligibility criteria, including age and diagnosis, to ensure accurate data collection and analysis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. All patients \>/= 18 years old and able to provide informed consent
2. Patients with a diagnosis of chronic pulmonary aspergillosis
3. To speak and understand English
4. Able to provide informed consent

Where it's running

• Ninewells Hospital & Medical School
  Dundee, United Kingdom Recruiting
• Imperial College London
  London, United Kingdom Recruiting
• Manchester NHS Foundation Trust
  Manchester, United Kingdom Recruiting

Study contacts

• Study coordinator: Dareen Marghlani, MSc
• Email: dsm20@ic.ac.uk
• Phone: dsm20@ic.ac.uk

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing nebulized amphotericin B and saline for chronic pulmonary aspergillosis treatment

  This study is testing if a nebulized form of amphotericin B can help people with chronic pulmonary aspergillosis feel better compared to using saline after they've already been treated with oral itraconazole.

  Recruiting Phase 3 Post Graduate Institute of Medical Education and Research, Chandigarh · Chandigarh, Chandigarh · NCT06447402

• Comparing oral itraconazole alone versus with glucocorticoids for lung disease overlap

  This study tests whether taking oral itraconazole alone or with glucocorticoids helps people with both Chronic Pulmonary Aspergillosis and Allergic Bronchopulmonary Aspergillosis feel better.

  Recruiting Post Graduate Institute of Medical Education and Research, Chandigarh · Chandigarh, Chandigarh and 1 other locations · NCT05444946

• Comparing two treatments for Chronic Pulmonary Aspergillosis

  This study is testing if a combination of two treatments can help people with Chronic Pulmonary Aspergillosis feel better compared to using just one of the treatments alone.

  Recruiting Phase 3 Poitiers University Hospital · Poitiers · NCT03656081

• PCR testing in blood and lung washings to monitor invasive pulmonary aspergillosis

  This will test whether repeated PCR tests for Aspergillus fumigatus in blood and bronchoalveolar lavage fluid can track treatment response in adults with invasive pulmonary aspergillosis.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07313527

• Breath analysis to detect fungal infections in leukemia patients

  This study is testing if analyzing breath samples can help doctors detect fungal infections in leukemia patients who are at high risk due to their treatment.

  Recruiting University of Zurich · Zurich, Canton of Zurich · NCT06537726

• Early diagnosis of invasive lung aspergillosis

  This study is trying to see if new tests can help doctors diagnose lung infections caused by fungus earlier in critically ill patients.

  Recruiting at 7 sites University Hospital Ostrava · Havířov, Moravian-Silesian Region and 6 other locations · NCT05860387

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.